Published

The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug and Alcohol Dependence
Date: 2014-12-15
Source: OpenAlex
DOI: 10.1016/j.drugalcdep.2014.09.060
PubMed: Unavailable

Authors

Frederick S. Barrett Matthew P. Bradstreet Jeannie-Marie Leoutsakos Matthew W. Johnson Katherine A. MacLean Robert L. Jesse Roland R. Griffiths

Watch author

Topics and keywords

psilocybin Pharmacology Other Psilocybin Hallucinogen Adverse effect Medicine Psychology Psychiatry Pharmacology Psychedelics and Drug Studies Mental Health and Psychiatry Psychotherapy Techniques and Applications

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin2014-12-15

Related papers

Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseJournal of Psychoactive Drugs · 2023-10-09 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24 Psilocybin-assisted therapy reduces heavy drinking in patients with AUDThe Brown University Psychopharmacology Update · 2022-11-02 Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effectsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-02-11 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology · 2025-08-28 630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-08 Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case reportBMC Psychiatry · 2025-02-27 Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experienceBJPsych Open · 2024-10-31